1L4D image
Entry Detail
PDB ID:
1L4D
Title:
CRYSTAL STRUCTURE OF MICROPLASMINOGEN-STREPTOKINASE ALPHA DOMAIN COMPLEX
Biological Source:
PDB Version:
Deposition Date:
2002-03-04
Release Date:
2002-12-11
Method Details:
Experimental Method:
Resolution:
2.30 Å
R-Value Free:
0.26
R-Value Work:
0.20
Space Group:
C 2 2 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:PLASMINOGEN
Mutations:S741A
Chain IDs:A
Chain Length:249
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:STREPTOKINASE
Chain IDs:B
Chain Length:122
Number of Molecules:1
Biological Source:Streptococcus dysgalactiae subsp. equisimilis
Ligand Molecules
Primary Citation
Effects of deletion of streptokinase residues 48-59 on plasminogen activation
PROTEIN ENG. 15 753 761 (2002)
PMID: 12456874 DOI: 10.1093/protein/15.9.753

Abstact

Streptokinase (SK) is a thrombolytic agent widely used for the clinical treatment of clotting disorders such as heart attack. The treatment is based on the ability of SK to bind plasminogen (Pg) or plasmin (Pm), forming complexes that proteolytically activate other Pg molecules to Pm, which carries out fibrinolysis. SK contains three major domains. The N-terminal domain, SKalpha, provides the complex with substrate recognition towards Pg. SKalpha contains a unique mobile loop, residues 45-70, absent in the corresponding domains of other bacterial Pg activators. To study the roles of this loop, we deleted 12 residues in this loop in both full-length SK and the SKalpha fragment. Kinetic data indicate that this loop participates in the recognition of substrate Pg, but does not function in the active site formation in the activator complex. Two crystal structures of the deletion mutant of SKalpha (SKalpha(delta)) complexed with the protease domain of Pg were determined. While the structure of SKalpha(delta) is essentially the same as this domain in full-length SK, the mode of SK-Pg interaction was however different from a previously observed structure. Even though mutagenesis studies indicated that the current complex represents a minor interacting form in solution, the binding to SKalpha(delta) triggered similar conformational changes in the Pg active site in both crystal forms.

Legend

Protein

Chemical

Disease

Primary Citation of related structures